Related Experiment Video
Updated: Jan 19, 2026

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
Treatment of depression in an adolescent with cardiomyopathy and arrhythmia
Canan Tanidir1, Ibrahim C Tanidir2, Volkan Tuzcu3
11Department of Child and Adolescent Psychiatry,Child and Adolescent Psychiatry Clinic,Bakirkoy State Hospital for Mental Health and Neurological Disorders,Istanbul,Turkey.
Abstract:
Patients with cardiomyopathy have a higher incidence of mood and anxiety disorders, resulting in greater probability for hospitalisation and increased risk for arrhythmia and death. We report a case of a 16-year-old boy with Danon disease, Wolff-Parkinson-White syndrome, and hypertrophic cardiomyopathy, who later developed depression and significant weight loss. The patient was successfully treated for his anxiety and depression with mirtazapine without any adverse cardiac effects.
Related Concept Videos
Vagus Nerve Stimulation Therapy to Manage Treatment-Resistant Depression
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
07:12Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
08:20MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...

